Management of peritoneal metastases - Basic concepts. [Review] (Record no. 1347)

MARC details
000 -LEADER
fixed length control field 03169nam a22003497a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160113s20152015 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1107-0625
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 26051329
245 ## - TITLE STATEMENT
Title Management of peritoneal metastases - Basic concepts. [Review]
251 ## - Source
Source Journal of B.U.On.. 20 Suppl 1:S2-11, 2015 May.
252 ## - Abbreviated Source
Abbreviated source J. Balk. Union Oncol.. 20 Suppl 1:S2-11, 2015 May.
253 ## - Journal Name
Journal name Journal of B.U.ON. : official journal of the Balkan Union of Oncology
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2015
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2015
266 ## - Date added to catalog
Date added to catalog 2016-01-13
520 ## - SUMMARY, ETC.
Abstract Despite the fact that cytoreductive surgery (CRS) and hyperthermic perioperative chemotherapy (HIPEC) is conceptually simplistic, optimal implementation of this combined treatment remains complex. Multiple patient-related variables, methodologic variables, and pharmacologic variables need to be considered in devising an optimal treatment strategy. Working through these variables considering the pathophysiology of peritoneal metastases and their possible treatments is more likely to provide guidance in terms of successful management than multiple randomized controlled trials. The principles of management include: 1) A surgical technology involving peritonectomy procedures and visceral resections that will result in a complete cytoreduction. 2) Treatment of patients at a maximal low peritoneal cancer index (PCI) will maximize the benefits especially in those patients who have high grade peritoneal metastases from gastric cancer, colorectal cancer, or ovarian malignancy. 3) Tumor cell entrapment should be avoided by preventing major surgical procedures prior to the definitive treatment with CRS and HIPEC. 4) Mechanical removal of cancer cells and small nodules by mechanical irrigation prior to HIPEC is necessary. 5) A response must be generated using cancer chemotherapy to eradicate small volume residual disease that will remain even after a complete cytoreduction by visual inspection. 6) The benefits of multiple cycles of normothermic intraperitoneal and intravenous chemotherapy (NIPEC) used long-term to help preserve the surgical complete response needs to be integrated into the overall plan of management. Currently, with peritoneal metastases from high grade disease perioperative chemotherapy usually fails to maintain the surgical complete response. Major modifications of the perioperative chemotherapy using HIPEC, early postoperative intraperitoneal chemotherapy (EPIC) and NIPEC long-term will go far towards optimizing the treatment of peritoneal metastases no matter what the primary gastrointestinal or gynecologic malignancy is being treated.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Peritoneal Neoplasms/sc [Secondary]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Peritoneal Neoplasms/th [Therapy]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytoreduction Surgical Procedures
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperthermia, Induced
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoadjuvant Therapy
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Surgery/General Surgery
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
657 ## - INDEX TERM--FUNCTION
Medline publication type Review
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Sugarbaker, Paul H
790 ## - Authors
All authors Sugarbaker PH
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Date last checked out Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 01/13/2016 1 26051329 26051329 09/26/2017 09/26/2017 01/13/2016 Journal Article

Powered by Koha